首页|马来酸噻吗洛尔凝胶联合595 nm脉冲染料激光治疗婴幼儿血管瘤临床疗效观察

马来酸噻吗洛尔凝胶联合595 nm脉冲染料激光治疗婴幼儿血管瘤临床疗效观察

扫码查看
目的 探讨马来酸噻吗洛尔凝胶联合595 nm脉冲染料激光治疗婴幼儿血管瘤的临床效果.方法 回顾性分析2016年1月至2022年1月河北省儿童医院60例浅表婴幼儿血管瘤患儿临床治疗的资料,根据治疗方法将60例患儿分成2组,每组30例.对照组应用595 nm脉冲染料激光治疗,观察组应用马来酸噻吗洛尔凝胶联合595 nm脉冲染料激光治疗.比较2组患儿临床疗效、总体激光治疗次数以及不良反应.比较2组治疗前后血清CXC趋化因子12(CXCL12)、血管内皮生长因子(VEGF)、色素上皮衍生因子(PEDF)及血管紧张素(Ang)水平,以及血管瘤活跃度评分表(HAS)、中文版婴儿血管瘤特异性生活质量问卷(IH-QOL)、家属汉密尔顿焦虑量表(HAMA)评分.结果 2组有效率比较差异无统计学意义(P>0.05).观察组激光治疗次数少于对照组,颜色转浅时间和面积缩小50%时间均少于对照组(P<0.05).治疗后,2组血清CXCL12、VEGF、Ang水平以及HAS、IH-QOL、家属HAMA评分均较本组治疗前降低,且观察组低于对照组(P<0.05);2组血清PEDF水平较治疗前升高,且观察组高于对照组(P<0.05).2组治疗过程中不良反应总发生率比较差异无统计学意义(P>0.05).结论 对婴幼儿血管瘤给予马来酸噻吗洛尔凝胶联合595 nm脉冲染料激光治疗,能够有效控制疾病进展,促进瘤体消退,改善血清相关因子水平、局部症状以及患儿和家属的生活质量,且安全可靠.
Clinical efficacy of timolol maleate gel combined with 595 nm pulsed dye laser in the treatment of infantile hemangioma
Objective To explore clinical efficacy of timolol maleate gel combined with 595 nm pulsed dye laser in the treatment of infantile hemangioma.Methods A retrospective analysis was conducted on the clinical data of 60 children diagnosed with superficial infantile hemangioma,who were treated at heibei children's hospital from January 2016 to January 2022.According to the treatment method,they were divided into a control group and an observation group,each comprising 30 cases.The control group was treated with 595 nm pulsed dye laser,and the observation group was treated with timolol maleate gel combined with 595 nm pulsed dye laser.The clinical efficacy,total number of laser treatments,and incidence of adverse reactions were then compared between the two groups.The other data were fuether collected and compared pre-and post-treatment between the two groups,including the serum levels of CXC chemokine 12(CXCL12),vascular endothelial growth factor(VEGF),pigment epithelial derived factor(PEDF),angiotensin(Ang),as well as the hemangioma activity scale(HAS),the Chinese version of the iInfant hemangioma specific quality of life questionnaire(IH-QOL)and family members Hamilton anxiety scale(HAMA)scores.Results There was no significant difference in total effective rate between the two groups(P>0.05).The total number of laser treatments,the time of color lightening and the time required for a 50%reduction in area were significantly lower in the observation group compared to the control group(P<0.05).After treatment,the serum levels of CXCL12,VEGF,and Ang,as well as the and HAS,IH-QOL and HAMA scores of family members,were significantly reduced in both groups compared to pre-treatment levels.Moreover,these reductions were more pronounced in the observation group compared to the control group(P<0.05).The serum PEDF levels in both groups were elevated compared to pre-treatment levels,with the observation group exhibiting a significantly higher increase than the control group.(P<0.05).There was no statistical significance in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Timolol maleate gel combined with 595 nm pulsed dye laser can effectively control the development of infantile hemangioma,promote tumor regression,improve the levels of serum-related factors,local symptoms and the quality of life of children and their families,demonstrating safety and reliability.

Hemangioma,infantTimolol maleate gelLasers

刘召明、李芳芳、高阳、李向静、薛磊

展开 >

050031 石家庄,河北省儿童医院

血管瘤,婴幼儿 马来酸噻吗洛尔凝胶 激光

2024

实用皮肤病学杂志
中国人民解放军北京军区总医院

实用皮肤病学杂志

CSTPCD
影响因子:0.637
ISSN:1674-1293
年,卷(期):2024.17(6)